Ivermectin increases striatal cholinergic activity to facilitate dopamine terminal function
Abstract Ivermectin (IVM) is a commonly prescribed antiparasitic treatment with pharmacological effects on invertebrate glutamate ion channels resulting in paralysis and death of invertebrates. However, it can also act as a modulator of some vertebrate ion channels and has shown promise in facilitat...
Main Authors: | Hillary A. Wadsworth, Alicia M. P. Warnecke, Joshua C. Barlow, J. Kayden Robinson, Emma Steimle, Joakim W. Ronström, Pacen E. Williams, Christopher J. Galbraith, Jared Baldridge, Michael W. Jakowec, Daryl L. Davies, Jordan T. Yorgason |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-04-01
|
Series: | Cell & Bioscience |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13578-024-01228-2 |
Similar Items
-
P2X4 receptors (P2X4Rs) represent a novel target for the development of drugs to prevent and/or treat alcohol use disorders
by: Kelle M. Franklin, et al.
Published: (2014-06-01) -
Serotonin as a biomarker of toxin-induced Parkinsonism
by: Anna Marie Buchanan, et al.
Published: (2024-03-01) -
P2Y1 purinergic receptor identified as a diabetes target in a small-molecule screen to reverse circadian β-cell failure
by: Biliana Marcheva, et al.
Published: (2022-02-01) -
Dopamine Receptor Blockade Attenuates Purinergic P2X4 Receptor-Mediated Prepulse Inhibition Deficits and Underlying Molecular Mechanisms
by: Sheraz Khoja, et al.
Published: (2019-07-01) -
Contrasting roles of the P2X4 receptor in inflammatory bowel disease
by: Ronald Sluyter
Published: (2023-06-01)